Forendo Pharma is a drug development company focusing on novel treatments in women's health. Its pipeline includes HSD17B1 inhibitor, FOR-6219 for the treatment of endometriosis; dual HSD inhibitors for the treatment of broader gynecological conditions; and Fispemifene, a novel SERM for the treatment of male urological conditions.
|Employees (est.) (Jun 2021)||25|
Forendo Pharma total Funding
Forendo Pharma latest funding size
Time since last funding
|2 years ago|
Forendo Pharma investors
|Novartis Venture Fund, Vesalius Biocapital Partners, MS Ventures, Novo Seeds, M Ventures, Business Finland, Innovestor, Karolinska, Sunstone Life Science Ventures|
When was Forendo Pharma founded?
Forendo Pharma was founded in 2013.
Who are Forendo Pharma key executives?
Forendo Pharma's key executives are Risto Lammintausta.
How many employees does Forendo Pharma have?
Forendo Pharma has 25 employees.
Who are Forendo Pharma competitors?
Competitors of Forendo Pharma include Fervent Pharmaceuticals, HRA Pharma and Ascend Therapeutics.
Where is Forendo Pharma headquarters?
Forendo Pharma headquarters is located at Österlånggatan 4b, Åbo.
Where are Forendo Pharma offices?
Forendo Pharma has an office in Åbo.
How many offices does Forendo Pharma have?
Forendo Pharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies